top of page
BioRN Team
Strategy & Mission
Strategy & Mission
BioRN Annual Conference 2018
BioRN Annual Conference 2018
HAE Visionary Seminar
Directory
Executive Board
Dr. Gitte Neubauer (Chair)
CEO of Cellzome GmbH - a GSK company, Heidelberg
Prof. Dr. Michael Boutros (Deputy Chair)
Head of Functional and Structural Genomics Program at the German Cancer Research Center (DKFZ), Heidelberg
Dr. André H.R. Domin
Managing Director of the Technologiepark Heidelberg GmbH, Heidelberg
Dr. Stefan Herr
CEO of EMBL Ventures GmbH, Heidelberg
Prof. Dr. Magnus von Knebel Doeberitz
Director, Department of Applied Tumor Biology, Institute of Pathology, University of Heidelberg
Dr. Volker Stadler
CEO of PEPperPRINT GmbH, Heidelberg
Dr. Axel Wiest
Chief Operating Officer R&D, Merck KGaA, Darmstadt
Dr. Ulrich Betz
Vice President of Innovation Merck KGaA, Darmstadt
Dr. André H.R. Domin
Managing Director of the Technologiepark Heidelberg GmbH, Heidelberg
Prof. Dr. Magnus von Knebel Doeberitz
Medical Director, Department of Applied Tumor Biology, Institute of Pathology, Heidelberg University Hospital
Dr. Claus Kremoser
CEO of Phenex Pharmaceuticals AG,
Head of the Supervisory Board of WMT,
Heidelberg
Dr. Volker Stadler
CEO of PEPperPRINT GmbH, Heidelberg
Strategic Advisory Board
The strategic board is an advisory body, endoursed with the task of advising the executive board particularly on strategic issues or reviewing executive board decisions.
Dr. Siegfried Bialojan, Biotech Expert
Prof. Dr. Bernd Bukau, Director of Zentrum für Molekulare Biologie Heidelberg (ZMBH)
Dr. Jürgen Gamer, VP Business Development Apogenix AG, Heidelberg
Dr. Jan Gradel, City of Heidelberg, Heidelberg
Martin Haag, Site Manager, Roche Diagnostics GmbH, Mannheim
Dr. Thomas Hanke, Evotec International GmbH, EVP, Head of Academic Partnerships, Hamburg
Prof. Dr. Carsten Hopf, Head of Institute for Instrumental Analytics and Bioanalytics Mannheim University of Applied Sciences
Andreas Kempff, Managing Director, Department of Industry, Innovation and Enterprise Promotion, Chamber of Industry and Commerce (IHK) Rhine-Neckar, Heidelberg
Michael Kring, Chief Financial Officer / Serial Entrepreneur / Investor
Dr. Bernd Nosse, Global Head BD&L Technologies and Research Beyond Boarders, Boehringer Ingelheim International GmbH, Ingelheim
Dr. Martin Raditsch, CEO INNOVECTIS GmbH, Frankfurt am Main
Dr. Chistian Tidona (Chair), Managing Director BioMed X GmbH, Heidelberg
Dr. Joachim Vogt, Director Search & Evaluation Western Europe at AbbVie
Dr. Alexander Wartini, CEO, ScienceValue Heidelberg GmbH Technology Transfer for the Ruprecht-Karls
University, Heidelberg
Dr. Rainer Wessel, Director Innovation Management, German Cancer Research Center (DKFZ), Heidelberg
Prof. Dr. Heike Andrea Wieland, Director External Ecosystem R&D, Sanofi-Aventis Deutschland GmbH, Frankfurt am Main
Scientific Advisory Board
The Scientific Advisory Board is an advisory body entrusted with the task of advising the executive board particularly in the selection and evaluation of project ideas and projects
Dr. Christoph Antz, CEO, VERAXA Biotech GmbH, Heidelberg
Dr. Juergen Bauer, Deputy Managing Director, EMBLEM Technology Transfer GmbH, Heidelberg
Prof. Dr. Adelheid Cerwenka, Professor of Immunobiochemistry Heidelberg University, Medical Faculty Mannheim
PD Dr. Gerard Drewes, Head of Science, Cellzome GmbH – a GSK company, Heidelberg
Prof. Dr. Mathias Hafner (Chair), Vice President for Research and Technology Transfer at Mannheim University of Applied Sciences
Dr. Lena Krzyzak, Principal in Life Science Team, High-Tech Gründerfonds
Dr. Thomas Höger, CEO and co-founder, Apogenix GmbH, Heidelberg
Dr. Friedrich Rippmann, Director, Computational Chemistry & Biology Global R&D, Discovery Technologies Merck KGaA, Darmstadt
Prof. Dr. Andreas Trumpp, Managing Director of HI-STEM, Professor and Head of the Division of Stem Cell and Cancer at the DKFZ Heidelberg
bottom of page